August 29, 2016

BioTelemetry, Inc. Announces CE Mark Approval of Holter Analysis Software

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that the Company has received CE mark approval of its Holter analysis software.